Latest features in GaBI Journal, 2016, Issue 3
Is the EU ready for non-biological complex drug products?
Biosimilars: achieving long-term savings and competitive markets
The generic medicines system in Italy: scenarios for sustainable growth
Pharmacovigilance on biologicals and biosimilars: a Danish perspective
Regional management of biosimilars in Germany
Biosimilars in Italy: a gastroenterologist’s view
Demonstrating interchangeability and biosimilarity for US biosimilars
US FDA proposals for naming of biologicals and labelling of biosimilars
Competitive effects on the generics industry
Source URL: https://gabi-journal.net/20163-gabi-journal-table-of-contents.html
Copyright ©2024 GaBI Journal unless otherwise noted.